In medio stat virtus: Unanticipated consequences of telomere dysequilibrium

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 373, Issue 1741, 2018, Pages

  Harrington, Lea ^a   Pucci, Fabio ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cell differentiation; Cell senescence; DNA methylation; Histones; Telomere dysequilibrium

Indexed keywords

CELL; CHEMICAL BINDING; CHROMOSOME; DIFFERENTIATION; DNA; ENZYME ACTIVITY; METHYLATION; PROTEIN; SENESCENCE;

MURINAE;

HISTONE; SHELTERIN, HUMAN; TELOMERE BINDING PROTEIN;

ANIMAL; CELL AGING; CELL DIFFERENTIATION; DNA METHYLATION; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; PRIMARY CELL CULTURE; PROTEIN PROCESSING; STEM CELL; TELOMERE; TELOMERE HOMEOSTASIS;

ANIMALS; CELL DIFFERENTIATION; CELLULAR SENESCENCE; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; PRIMARY CELL CULTURE; PROTEIN PROCESSING, POST-TRANSLATIONAL; STEM CELLS; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE-BINDING PROTEINS;

EID: 85040666428     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2016.0444     Document Type: Review

References (142)

1. Campisi J. 2012 Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 75, 685-705. (doi: 10.1146/annurev-physiol-030212-183653)
2. De Lange T. 2005 Telomere-related genome instability in cancer. Cold Spring Harb. Symp. Quant. Biol. 70, 197-204. (doi: 10.1101/sqb.2005.70.032)
3. Reaper PM, di Fagagna F, Jackson SP. 2004 Activation of the DNA damage response by telomere attrition: a passage to cellular senescence. Cell Cycle 3, 543-546. (doi: 10.4161/cc.3.5.835)
4. Hug N, Lingner J. 2006 Telomere length homeostasis. Chromosoma 115, 413-425. (doi: 10.1007/s00412-006-0067-3)
5. Kalmbach K, Robinson Jr LG, Wang F, Liu L, Keefe D. 2014 Telomere length reprogramming in embryos and stem cells. BioMed Res. Int. 2014, 925121. (doi: 10.1155/2014/925121)
6. Harrington L. 2012 Haploinsufficiency and telomere length homeostasis. Mutat. Res. 730, 37-42. (doi: 10.1016/j.mrfmmm.2011.11.004)
7. Lundblad V, Szostak JW. 1989 A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 57, 633-643. (doi: 10.1016/0092-8674(89)90132-3)
8. Lundblad V, Blackburn EH. 1990 RNA-dependent polymerase motifs in EST1: tentative identification of a protein component of an essential yeast telomerase. Cell 60, 529-530. (doi: 10.1016/0092-8674(90)90653-V)
9. Lendvay TS, Morris DK, Sah J, Balasubramanian B, Lundblad V. 1996 Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics 144, 1399-1412.
10. Hayflick L, Moorhead PS. 1961 The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621. (doi: 10.1016/0014-4827(61)90192-6)
11. Harley CB, Futcher AB, Greider CW. 1990 Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460. (doi: 10.1038/345458a0)
12. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. 1990 Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866-868. (doi: 10.1038/346866a0)
13. Cesare AJ, Karlseder J. 2012 A three-state model of telomere control over human proliferative boundaries. Curr. Opin. Cell Biol. 24, 731-738. (doi: 10.1016/j.ceb.2012.08.007)
14. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S. 1992 Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921-1929.
15. Pickett HA, Reddel RR. 2015 Molecular mechanisms of activity and derepression of alternative lengthening of telomeres. Nat. Struct. Mol. Biol. 22, 875-880. (doi: 10.1038/nsmb.3106)
16. Conomos D, Reddel RR, Pickett HA. 2014 NuRDZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination. Nat. Struct. Mol. Biol. 21, 760-770. (doi: 10.1038/nsmb.2877)
17. Roake CM, Artandi SE. 2016 DNA repair: telomerelengthening mechanism revealed. Nature 539, 35-36. (doi: 10.1038/nature19483)
18. Dugdale HL, Richardson DS. 2018 Heritability of telomere variation: it is all about the environment! Phil. Trans. R. Soc. B 373, 20160450. (doi: 10.1098/rstb.2016.0450)
19. Entringer S, de Punder K, Buss C, Wadhwa PD. 2018 The fetal programming of telomere biology hypothesis: an update. Phil. Trans. R. Soc. B 373, 20170151. (doi: 10.1098/rstb.2017.0151)
20. Stewart JA, Chaiken MF, Wang F, Price CM. 2012 Maintaining the end: roles of telomere proteins in end-protection, telomere replication and length regulation. Mutat. Res. 730, 12-19. (doi: 10.1016/j.mrfmmm.2011.08.011)
21. Cifuentes-Rojas C, Shippen DE. 2012 Telomerase regulation. Mutat. Res. 730, 20-27. (doi: 10.1016/j.mrfmmm.2011.10.003)
22. Stanley SE, Armanios M. 2015 The short and long telomere syndromes: paired paradigms for molecular medicine. Curr. Opin. Genet. Dev. 33, 1-9. (doi: 10.1016/j.gde.2015.06.004)
23. Aviv A, Shay JW. 2018 Reflections on telomere dynamics and ageing-related diseases in humans. Phil. Trans. R. Soc. B 373, 20160436. (doi: 10.1098/rstb.2016.0436)
24. Criscuolo F, Smith S, Zahn S, Heidinger BJ, Haussmann MF. 2018 Experimental manipulation of telomere length: does it reveal a corner-stone role for telomerase in the natural variability of individual fitness? Phil. Trans. R. Soc. B 373, 20160440. (doi: 10.1098/rstb.2016.0440)
25. Tian X, Doerig K, Park R, Can Ran Qin A, Hwang C, Neary A, Gilbert M, Seluanov A, Gorbunova V. 2018 Evolution of telomere maintenance and tumour suppressor mechanisms across mammals. Phil. Trans. R. Soc. B 373, 20160443. (doi: 10.1098/rstb.2016.0443)
26. Tricola GM et al. 2018 The rate of telomere loss is related to maximum lifespan in birds. Phil. Trans. R. Soc. B 373, 20160445. (doi: 10.1098/rstb.2016.0445)
27. Monaghan P, Ozanne SE. 2018 Somatic growth and telomere dynamics in vertebrates: relationships, mechanisms and consequences. Phil. Trans. R. Soc. B 373, 20160446. (doi: 10.1098/rstb.2016.0446)
28. Wilbourn RV, Moatt JP, Froy H, Walling CA, Nussey DH, Boonekamp JJ. 2018 The relationship between telomere length and mortality risk in non-model vertebrate systems: a meta-analysis. Phil. Trans. R. Soc. B 373, 20160447. (doi: 10.1098/rstb.2016.0447)
29. Olsson M, Wapstra E, Friesen C. 2018 Ectothermic telomeres: it’s time they came in from the cold. Phil. Trans. R. Soc. B 373, 20160449. (doi: 10.1098/rstb.2016.0449)
30. Young AJ. 2018 The role of telomeres in the mechanisms and evolution of life-history trade-offs and ageing. Phil. Trans. R. Soc. B 373, 20160452. (doi: 10.1098/rstb.2016.0452)
31. -/- mice with short telomeres. EMBO Rep. 2, 1-8. (doi: 10.1093/emboreports/kve174)
32. Hemann MT, Strong MA, Hao L-Y, Greider CW. 2001 The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107, 67-77. (doi: 10.1016/S0092-8674(01)00504-9)
33. Claussin C, Chang M. 2016 Multiple Rad52- mediated homology-directed repair mechanisms are required to prevent telomere attrition-induced senescence in Saccharomyces cerevisiae. PLoS Genet. 12, e1006176. (doi: 10.1371/journal.pgen.1006176)
34. van Mourik PM, de Jong J, Agpalo D, Claussin C, Rothstein R, Chang M. 2016 Recombinationmediated telomere maintenance in Saccharomyces cerevisiae is not dependent on the Shu complex. PLoS ONE 11, e0151314. (doi: 10.1371/journal.pone.0151314)
35. Harari Y, Romano GH, Ungar L, Kupiec M. 2013 Nature vs nurture: interplay between the genetic control of telomere length and environmental factors. Cell Cycle 12, 3465-3470. (doi: 10.4161/cc.26625)
36. Greider CW. 2016 Regulating telomere length from the inside out: the replication fork model. Genes Dev. 30, 1483-1491. (doi: 10.1101/gad.280578.116)
37. Murnane JP. 2012 Telomere dysfunction and chromosome instability. Mutat. Res. 730, 28-36. (doi: 10.1016/j.mrfmmm.2011.04.008)
38. Poole LA, Zhao R, Glick GG, Lovejoy CA, Eischen CM, Cortez D. 2015 SMARCAL1 maintains telomere integrity during DNA replication. Proc. Natl Acad. Sci. USA 112, 14864-14869. (doi: 10.1073/pnas.1510750112)
39. Takai KK, Hooper S, Blackwood S, Gandhi R, de Lange T. 2010 In vivo stoichiometry of shelterin components. J. Biol. Chem. 285, 1457-1467. (doi: 10.1074/jbc.M109.038026)
40. Chen LY, Lingner J. 2013 CST for the grand finale of telomere replication. Nucleus 4, 277-282. (doi: 10.4161/nucl.25701)
41. Feng X, Hsu SJ, Kasbek C, Chaiken M, Price CM. 2017 CTC1-mediated C-strand fill-in is an essential step in telomere length maintenance. Nucleic Acids Res. 45, 4281-4293. (doi: 10.1093/nar/gkx125)
42. Fairlie J, Harrington L. 2015 Enforced telomere elongation increases the sensitivity of human tumour cells to ionizing radiation. DNA Repair (Amst) 25, 54-59. (doi: 10.1016/j.dnarep.2014.11.005)
43. Lovejoy CA et al. 2012 Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet. 8, e1002772. (doi: 10.1371/journal.pgen.1002772)
44. Sfeir A, Kosiyatrakul ST, Hockemeyer D, MacRae SL, Karlseder J, Schildkraut CL, de Lange T. 2009 Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138, 90-103. (doi: 10.1016/j.cell.2009.06.021)
45. Rivera T, Haggblom C, Cosconati S, Karlseder J. 2017 A balance between elongation and trimming regulates telomere stability in stem cells. Nat. Struct. Mol. Biol. 24, 30-39. (doi: 10.1038/nsmb.3335)
46. Harari Y, Kupiec M. 2017 Mec1ATR is needed for extensive telomere elongation in response to ethanol in yeast. Curr. Genet. (doi: 10.1007/s00294-017-0728-1)
47. Lee SS, Bohrson C, Pike AM, Wheelan SJ, Greider CW. 2015 ATM kinase is required for telomere elongation in mouse and human cells. Cell Rep. 13, 1623-1632. (doi: 10.1016/j.celrep.2015.10.035)
48. Tong AS, Stern JL, Sfeir A, Kartawinata M, de Lange T, Zhu XD, Bryan TM. 2015 ATM and ATR signaling regulate the recruitment of human telomerase to telomeres. Cell Rep. 13, 1633-1646. (doi: 10.1016/j.celrep.2015.10.041)
49. Potrony M, Badenas C, Aguilera P, Puig-Butille JA, Carrera C, Malvehy J, Puig S. 2015 Update in genetic susceptibility in melanoma. Ann. Transl. Med. 3, 210.
50. Ramlee MK, Wang J, Toh WX, Li S. 2016 Transcription regulation of the human telomerase reverse transcriptase (hTERT) gene. Genes (Basel) 7, e50. (doi: 10.3390/genes7080050)
51. Risques RA, Promislow DEL. 2018 All’s well that ends well: why large species have short telomeres. Phil. Trans. R. Soc. B 373, 20160448. (doi: 10.1098/rstb.2016.0448)
52. Vermeesch JR, Williams D, Price CM. 1993 Telomere processing in Euplotes. Nucleic Acids Res. 21, 5366-5371. (doi: 10.1093/nar/21.23.5366)
53. Bhattacharyya MK, Lustig AJ. 2006 Telomere dynamics in genome stability. Trends Biochem. Sci. 31, 114-122. (doi: 10.1016/j.tibs.2005.12.001)
54. Watson JM, Shippen DE. 2007 Telomere rapid deletion regulates telomere length in Arabidopsis thaliana. Mol. Cell. Biol. 27, 1706-1715. (doi: 10.1128/MCB.02059-06)
55. Bechard LH, Jamieson N, McEachern MJ. 2011 Recombination can cause telomere elongations as well as truncations deep within telomeres in wildtype Kluyveromyces lactis cells. Eukaryot. Cell 10, 226-236. (doi: 10.1128/EC.00209-10)
56. Pickett HA, Cesare AJ, Johnston RL, Neumann AA, Reddel RR. 2009 Control of telomere length by a trimming mechanism that involves generation of t-circles. EMBO J. 28, 799-809. (doi: 10.1038/emboj.2009.42)
57. Pickett HA, Henson JD, Au AY, Neumann AA, Reddel RR. 2011 Normal mammalian cells negatively regulate telomere length by telomere trimming. Hum. Mol. Genet. 20, 4684-4692. (doi: 10.1093/hmg/ddr402)
58. Henson JD, Cao Y, Huschtscha LI, Chang AC, Au AY, Pickett HA, Reddel RR. 2009 DNA C-circles are specific and quantifiable markers of alternativelengthening- of-telomeres activity. Nat. Biotechnol. 27, 1181-1185. (doi: 10.1038/nbt.1587)
59. Basenko EY, Cesare AJ, Iyer S, Griffith JD, McEachern MJ. 2010 Telomeric circles are abundant in the stn1-M1 mutant that maintains its telomeres through recombination. Nucleic Acids Res. 38, 182-189. (doi: 10.1093/nar/gkp814)
60. Cesare AJ, Griffith JD. 2004 Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol. Cell. Biol. 24, 9948-9957. (doi: 10.1128/MCB.24.22.9948-9957.2004)
61. Cesare AJ, Groff-Vindman C, Compton SA, McEachern MJ, Griffith JD. 2008 Telomere loops and homologous recombination-dependent telomeric circles in a Kluyveromyces lactis telomere mutant strain. Mol. Cell. Biol. 28, 20-29. (doi: 10.1128/MCB.01122-07)
62. Boeck G D, Forsyth RG, Praet M, Hogendoorn PC. 2009 Telomere-associated proteins: cross-talk between telomere maintenance and telomerelengthening mechanisms. J. Pathol. 217, 327-344. (doi: 10.1002/path.2500)
63. Compton SA, Choi JH, Cesare AJ, Ozgur S, Griffith JD. 2007 Xrcc3 and Nbs1 are required for the production of extrachromosomal telomeric circles in human alternative lengthening of telomere cells. Cancer Res. 67, 1513-1519. (doi: 10.1158/0008-5472.CAN-06-3672)
64. Oganesian L, Karlseder J. 2011 Mammalian 50 C-rich telomeric overhangs are a mark of recombinationdependent telomere maintenance. Mol. Cell 42, 224-236. (doi: 10.1016/j.molcel.2011.03.015)
65. Wang RC, Smogorzewska A, de Lange T. 2004 Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 119, 355-368. (doi: 10.1016/j.cell.2004.10.011)
66. Rai R, Hu C, Broton C, Chen Y, Lei M, Chang S. 2018 NBS1 phosphorylation status dictates repair choice of dysfunctional telomeres. Mol. Cell 65, 801-17 e4.
67. Jahn A et al. 2017 ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator. EMBO Rep. 18, 929-946. (doi: 10.15252/embr.201744095)
68. Li JS, Miralles Fuste J, Simavorian T, Bartocci C, Tsai J, Karlseder J, Lazzerini Denchi E. 2017 TZAP: a telomere-associated protein involved in telomere length control. Science 355, 638-641. (doi: 10.1126/science.aah6752)
69. Harari Y, Kupiec M. 2017 Do long telomeres affect cellular fitness? Curr. Genet. (doi: 10.1007/s00294-017-0746-z)
70. Harari Y, Zadok-Laviel S, Kupiec M. 2017 Long telomeres do not affect cellular fitness in yeast. MBio 8, e01314-17. (doi: 10.1128/mBio.01314-17)
71. Feinberg AP, Vogelstein B. 1983 Hypomethylation of ras oncogenes in primary human cancers. Biochem. Biophys. Res. Commun. 111, 47-54. (doi: 10.1016/S0006-291X(83)80115-6)
72. Feinberg AP, Vogelstein B. 1983 Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89-92. (doi: 10.1038/301089a0)
73. Wilson VL, Jones PA. 1983 DNA methylation decreases in aging but not in immortal cells. Science 220, 1055-1057. (doi: 10.1126/science.6844925)
74. Decottignies A, d’Adda di Fagagna F. 2011 Epigenetic alterations associated with cellular senescence: a barrier against tumorigenesis or a red carpet for cancer? Semin. Cancer Biol. 21, 360-366. (doi: 10.1016/j.semcancer.2011.09.003)
75. Hannum G et al. 2013 Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol. Cell 49, 359-367. (doi: 10.1016/j.molcel.2012.10.016)
76. Bocklandt S, Lin W, Sehl ME, Sanchez FJ, Sinsheimer JS, Horvath S, Vilain E. 2011 Epigenetic predictor of age. PLoS ONE 6, e14821. (doi: 10.1371/journal.pone.0014821)
77. Armstrong NJ et al. 2017 Aging, exceptional longevity and comparisons of the Hannum and Horvath epigenetic clocks. Epigenomics 9, 689-700. (doi: 10.2217/epi-2016-0179)
78. Thompson MJ, von Holdt B, Horvath S, Pellegrini M. 2017 An epigenetic aging clock for dogs and wolves. Aging (Albany NY) 9, 1055-1068.
79. Field AE, Adams PD. 2017 Targeting chromatin aging-the epigenetic impact of longevityassociated interventions. Exp. Gerontol. 94, 29-33. (doi: 10.1016/j.exger.2016.12.010)
80. Wang T et al. 2017 Epigenetic aging signatures in mice livers are slowed by dwarfism, calorie restriction and rapamycin treatment. Genome Biol. 18, 57. (doi: 10.1186/s13059-017-1186-2)
81. Horvath S. 2013 DNA methylation age of human tissues and cell types. Genome Biol. 14, R115. (doi: 10.1186/gb-2013-14-10-r115)
82. Hadad N et al. 2016 Absence of genomic hypomethylation or regulation of cytosinemodifying enzymes with aging in male and female mice. Epigenet. Chromatin 9, 30. (doi: 10.1186/s13072-016-0080-6)
83. Huang K, Fan G. 2010 DNA methylation in cell differentiation and reprogramming: an emerging systematic view. Regen. Med. 5, 531-544. (doi: 10.2217/rme.10.35)
84. Hombach-Klonisch S et al. 2008 Adult stem cells and their trans-differentiation potential- perspectives and therapeutic applications. J. Mol. Med. (Berl.) 86, 1301-1314. (doi: 10.1007/s00109-008-0383-6)
85. Scheel C, Weinberg RA. 2012 Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin. Cancer Biol. 22, 396-403. (doi: 10.1016/j.semcancer.2012.04.001)
86. Gedye C. 2013 Heterogeneity in cancer: the ‘cancer stem cell’ hypothesis. In The basic science of oncology 1 (eds I Tannock, R Hill, R Bristow, L Harrington), p. 575. New York, NY: McGraw Hill.
87. Benetti R, Garcia-Cao M, Blasco MA. 2007 Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat. Genet. 39, 243-250. (doi: 10.1038/ng1952)
88. Schoeftner S, Blasco MA. 2009 A ‘higher order’ of telomere regulation: telomere heterochromatin and telomeric RNAs. EMBO J. 28, 2323-2336. (doi: 10.1038/emboj.2009.197)
89. Benetti R, Gonzalo S, Jaco I, Schotta G, Klatt P, Jenuwein T, Blasco MA. 2007 Suv4-20 h deficiency results in telomere elongation and derepression of telomere recombination. J. Cell Biol. 178, 925-936. (doi: 10.1083/jcb.200703081)
90. Ferron SR, Marques-Torrejon MA, Mira H, Flores I, Taylor K, Blasco MA, Farinas I. 2009 Telomere shortening in neural stem cells disrupts neuronal differentiation and neuritogenesis. J. Neurosci. 29, 14394-14407. (doi: 10.1523/JNEUROSCI.3836-09.2009)
91. Wang F et al. 2012 Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells. Cell Res. 22, 757-768. (doi: 10.1038/cr.2011.201)
92. Wang H, Chen Q, Lee SH, Choi Y, Johnson FB, Pignolo RJ. 2012 Impairment of osteoblast differentiation due to proliferation-independent telomere dysfunction in mouse models of accelerated aging. Aging Cell 11, 704-713. (doi: 10.1111/j.1474-9726.2012.00838.x)
93. Heng JC, Orlov YL, Ng HH. 2010 Transcription factors for the modulation of pluripotency and reprogramming. Cold Spring Harb. Symp. Quant. Biol. 75, 237-244. (doi: 10.1101/sqb.2010.75.003)
94. Li YQ. 2010 Master stem cell transcription factors and signaling regulation. Cell. Reprogram. 12, 3-13. (doi: 10.1089/cell.2009.0033)
95. Huang J et al. 2011 Association of telomere length with authentic pluripotency of ES/iPS cells. Cell Res. 21, 779-792. (doi: 10.1038/cr.2011.16)
96. Agarwal S et al. 2010 Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 464, 292-296. (doi: 10.1038/nature08792)
97. Batista LF et al. 2011 Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature 474, 399-402. (doi: 10.1038/nature10084)
98. Marion RM, Strati K, Li H, Tejera A, Schoeftner S, Ortega S, Serrano M, Blasco MA. 2009 Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4, 141-154. (doi: 10.1016/j.stem.2008.12.010)
99. Pucci F, Gardano L, Harrington L. 2013 Short telomeres in ESCs lead to unstable differentiation. Cell Stem Cell 12, 479-486. (doi: 10.1016/j.stem.2013.01.018)
100. Aguado T, Gutierrez FJ, Aix E, Schneider RP, Giovinazzo G, Blasco MA, Flores I. 2017 Telomere length defines the cardiomyocyte differentiation potency of mouse induced pluripotent stem cells. Stem Cells 35, 362-373. (doi: 10.1002/stem.2497)
101. Schmidt CS et al. 2013 Global DNA hypomethylation prevents consolidation of differentiation programs and allows reversion to the embryonic stem cell state. PLoS ONE 7, e52629. (doi: 10.1371/journal.pone.0052629)
102. Sinkkonen L, Hugenschmidt T, Berninger P, Gaidatzis D, Mohn F, Artus-Revel CG, Zavolan M, Svoboda P, Filipowicz W. 2008 MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat. Struct. Mol. Biol. 15, 259-267. (doi: 10.1038/nsmb.1391)
103. Roberts AR, Huang E, Jones L, Daxinger L, Chong S, Whitelaw E. 2013 Non-telomeric epigenetic and genetic changes are associated with the inheritance of shorter telomeres in mice. Chromosoma 122, 541-554. (doi: 10.1007/s00412-013-0427-8)
104. O’Sullivan RJ, Karlseder J. 2012 The great unravelling: chromatin as a modulator of the aging process. Trends Biochem. Sci. 37, 466-476. (doi: 10.1016/j.tibs.2012.08.001)
105. Platt JM et al. 2013 Rap1 relocalization contributes to the chromatin-mediated gene expression profile and pace of cell senescence. Genes Dev. 27, 1406-1420. (doi: 10.1101/gad.218776.113)
106. Martin SG, Laroche T, Suka N, Grunstein M, Gasser SM. 1999 Relocalization of telomeric Ku and SIR proteins in response to DNA strand breaks in yeast. Cell 97, 621-633. (doi: 10.1016/S0092-8674(00)80773-4)
107. Shore D. 1994 RAP1: a protean regulator in yeast. Trends Genet. 10, 408-412. (doi: 10.1016/0168-9525(94)90058-2)
108. Morse RH. 2000 RAP, RAP, open up! New wrinkles for RAP1 in yeast. Trends Genet. 16, 51-53. (doi: 10.1016/S0168-9525(99)01936-8)
109. Smogorzewska A, de Lange T. 2004 Regulation of telomerase by telomeric proteins. Annu. Rev. Biochem. 73, 177-208. (doi: 10.1146/annurev.biochem.73.071403.160049)
110. Kabir S, Sfeir A, de Lange T. 2010 Taking apart Rap1: an adaptor protein with telomeric and nontelomeric functions. Cell Cycle 9, 4061-4067. (doi: 10.4161/cc.9.20.13579)
111. Sfeir A, Kabir S, van Overbeek M, Celli GB, de Lange T. 2010 Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal. Science 327, 1657-1661. (doi: 10.1126/science.1185100)
112. Teo H et al. 2010 Telomere-independent Rap1 is an IKK adaptor and regulates NF-kB-dependent gene expression. Nat. Cell Biol. 12, 758-767. (doi: 10.1038/ncb2080)
113. Martinez P et al. 2010 Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites. Nat. Cell Biol. 12, 768-780. (doi: 10.1038/ncb2081)
114. Yeung F, Ramirez CM, Mateos-Gomez PA, Pinzaru A, Ceccarini G, Kabir S, Fernández-Hernando C, Sfeir A. 2013 Nontelomeric role for Rap1 in regulating metabolism and protecting against obesity. Cell Rep. 3, 1847-1856. (doi: 10.1016/j.celrep.2013.05.032)
115. Martinez P, Gomez-Lopez G, Garcia F, Mercken E, Mitchell S, Flores JM, de Cabo R, Blasco MA. 2013 RAP1 protects from obesity through its extratelomeric role regulating gene expression. Cell Rep. 3, 2059-2074. (doi: 10.1016/j.celrep.2013.05.030)
116. Martinez P, Gomez-Lopez G, Pisano DG, Flores JM, Blasco MA. 2016 A genetic interaction between RAP1 and telomerase reveals an unanticipated role for RAP1 in telomere maintenance. Aging Cell 15, 1113-1125. (doi: 10.1111/acel.12517)
117. d’Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP. 2003 A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194-198. (doi: 10.1038/nature02118)
118. Hauer MH et al. 2017 Histone degradation in response to DNA damage enhances chromatin dynamics and recombination rates. Nat. Struct. Mol. Biol. 24, 99-107. (doi: 10.1038/nsmb.3347)
119. Chen H, Ruiz PD, McKimpson WM, Novikov L, Kitsis RN, Gamble MJ. 2015 MacroH2A1 and ATM play opposing roles in paracrine senescence and the senescence-associated secretory phenotype. Mol. Cell 59, 719-731. (doi: 10.1016/j.molcel.2015.07.011)
120. Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, Blasco MA. 2006 DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat. Cell Biol. 8, 416-424. (doi: 10.1038/ncb1386)
121. Cruickshanks HA et al. 2013 Senescent cells harbour features of the cancer epigenome. Nat. Cell Biol. 15, 1495-1506. (doi: 10.1038/ncb2879)
122. De Cecco M et al. 2013 Genomes of replicatively senescent cells undergo global epigenetic changes leading to gene silencing and activation of transposable elements. Aging Cell 12, 247-256. (doi: 10.1111/acel.12047)
123. Gordon K, Clouaire T, Bao XX, Kemp SE, Xenophontos M, de Las Heras JI, Stancheva I. 2014 Immortality, but not oncogenic transformation, of primary human cells leads to epigenetic reprogramming of DNA methylation and gene expression. Nucleic Acids Res. 42, 3529-3541. (doi: 10.1093/nar/gkt1351)
124. Nelson DM, McBryan T, Jeyapalan JC, Sedivy JM, Adams PD. 2014 A comparison of oncogeneinduced senescence and replicative senescence: implications for tumor suppression and aging. Age (Dordr.) 36, 9637. (doi: 10.1007/s11357-014-9637-0)
125. Lowe D, Horvath S, Raj K. 2016 Epigenetic clock analyses of cellular senescence and ageing. Oncotarget 7, 8524-8531. (doi: 10.18632/oncotarget.7383)
126. McClay JL et al. 2014 A methylome-wide study of aging using massively parallel sequencing of the methyl-CpG-enriched genomic fraction from blood in over 700 subjects. Hum. Mol. Genet. 23, 1175-1185. (doi: 10.1093/hmg/ddt511)
127. Lau CH, Suh Y. 2017 Genome and epigenome editing in mechanistic studies of human aging and aging-related disease. Gerontology 63, 103-117. (doi: 10.1159/000452972)
128. Stadler G, Rahimov F, King OD, Chen JC, Robin JD, Wagner KR, Shay JW, Emerson CP, Wright WE. 2013 Telomere position effect regulates DUX4 in human facioscapulohumeral muscular dystrophy. Nat. Struct. Mol. Biol. 20, 671-678. (doi: 10.1038/nsmb.2571)
129. Luke-Glaser S, Poschke H, Luke B. 2012 Getting in (and out of) the loop: regulating higher order telomere structures. Front. Oncol. 2, 180. (doi: 10.3389/fonc.2012.00180)
130. Mosteiro L et al. 2016 Tissue damage and senescence provide critical signals for cellular reprogramming in vivo. Science 354, aaf4445. (doi: 10.1126/science.aaf4445)
131. Takahashi K, Yamanaka S. 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. (doi: 10.1016/j.cell.2006.07.024)
132. Jones CH, Pepper C, Baird DM. 2012 Telomere dysfunction and its role in haematological cancer. Br. J. Haematol. 156, 573-587. (doi: 10.1111/j.1365-2141.2011.09022.x)
133. Shay JW, Wright WE. 2011 Role of telomeres and telomerase in cancer. Semin. Cancer Biol. 21, 349-353. (doi: 10.1016/j.semcancer.2011.10.001)
134. Hirashima K, Migita T, Sato S, Muramatsu Y, Ishikawa Y, Seimiya H. 2013 Telomere length influences cancer cell differentiation in vivo. Mol. Cell. Biol. 33, 2988-2995. (doi: 10.1128/MCB.00136-13)
135. Kreiling JA et al. 2010 Age-associated increase in heterochromatic marks in murine and primate tissues. Aging Cell 10, 292-304. (doi: 10.1111/j.1474-9726.2010.00666.x)
136. Liu Y, Harrington L. 2012 Murine models of dysfunctional telomeres and telomerase. In Telomerases: chemistry, biology, and clinical applications (eds C Autexier, NF Lue), 1st edn, pp. 213-239. New York, NY: John Wiley & Sons.
137. Meznikova M, Erdmann N, Allsopp R, Harrington LA. 2009 Telomerase reverse transcriptase-dependent telomere equilibration mitigates tissue dysfunction in mTert heterozygotes. Dis. Model Mech. 2, 620-626. (doi: 10.1242/dmm.004069)
138. Erdmann N, Liu Y, Harrington L. 2004 Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice. Proc. Natl Acad. Sci. USA 101, 6080-6085. (doi: 10.1073/pnas.0401580101)
139. Jaskelioff M et al. 2010 Telomerase reactivation reverses tissue degeneration in aged telomerasedeficient mice. Nature 469, 102-106. (doi: 10.1038/nature09603)
140. Ding Z et al. 2012 Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases. Cell 148, 896-907. (doi: 10.1016/j.cell.2012.01.039)
141. Allsopp RC, Morin GB, De Pinho R, Harley CB, Weissman IL. 2003 Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood 102, 517-520. (doi: 10.1182/blood-2002-07-2334)
142. Beerman I, Bock C, Garrison BS, Smith ZD, Gu H, Meissner A, Rossi DJ. 2013 Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. Cell Stem Cell 12, 413-425. (doi: 10.1016/j.stem.2013.01.017)